Company
Allay Therapeutics
The first technology designed to deliver weeks of localized pain management
Also known as Allay Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- patients and physicians
- Legal name
- Allay Therapeutics, Inc.
- allaytx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Allay Therapeutics is pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation for patients and physicians.
Funding snapshot
- Total raised
- $163MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Undisclosed, $57.5M2025-06-05
Funding rounds
- Series D
- $57.5M2025-06-05, Company stated
- Round, 2025
- $45M2025-01-24, SEC form D sold, 18 investors
- Round, 2021
- $86.9M2021-09-09, SEC form D sold, 22 investors
- Round, 2020
- $15M2020-04-17, SEC form D sold, 7 investors
- Round, 2019
- $15.8M2019-01-31, SEC form D sold, 14 investors
Products
- Other
- ATX101
Loading relationship preview